PHT, Almac and Medidata Demonstrate New Level of eClinical Efficiencies at Data Integration Seminars
eClinical leaders deliver a strategy to improve efficiencies and cost savings in trial sponsors' eClinical data management BOSTON--(BUSINESS WIRE)--Three eClinical technology leaders will host ...
Swiss biopharma Debiopharm International negotiated global rights to Almac Discovery’s Wee-1 kinase inhibitor program. The deal gives Debiopharm exclusive rights to Almac Discovery’s Wee-1 patent ...
Thymidylate synthase will be tested as a marker of response to Alimta plus cisplatin in nonsquamous form of the disease. Eli Lilly has signed on Almac to develop a companion diagnostic for use along ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results